|
W. Mark Saltzman, Ph.D.
Goizueta Foundation Professor of Biomedical and Chemical Engineering and Professor of Cellular and Molecular Physiology
Department: FASEAS Dept of Biomedical Engineering (SEAS)
Education: B.S. Iowa State University, M.S. Massachusetts Institute of Technology, Ph.D. Massachusetts Institute of Technology
W. Mark Saltzman is an engineer and educator. His research has impacted the fields of drug delivery, biomaterials, nanobiotechnology, and tissue engineering: this work is described in 300 research papers and patents. He is also the sole author of three textbooks: Biomedical Engineering (Second Edition, 2015), Tissue Engineering (2004), and Drug Delivery (2001).
The grandson of farmers from southern Iowa, Mark Saltzman graduated with distinction from Iowa State University with a B.S. in chemical engineering (1981), earning admission to graduate school at the Massachusetts Institute of Technology, where he received an M.S. in chemical engineering (1984) and a Ph.D. in medical engineering (1987). He was hired as an assistant professor of chemical engineering at Johns Hopkins University in 1987 and promoted through the ranks, becoming a tenured full professor in 1995. In 1996, he joined the faculty of chemical engineering at Cornell University, where he was named the first BP Amoco/H. Laurance Fuller Chair in Chemical Engineering. Dr. Saltzman moved to Yale University as the Goizueta Foundation Professor of Chemical and Biomedical Engineering in July of 2002, where he became the founding chair of the Yale’s Department of Biomedical Engineering in 2003. |
|
Young-Eun Seo, Ph.D.
Education: B.A. Molecular & Cell Biology, University of California Berkeley, Ph.D. Biomedical Engineering, Yale University
Research Interests: nanoparticles for targeted brain tumor therapy, convection-enhanced delivery, miRNA-based therapeutics
|
|
Elias Quijano,
MD-PhD Student
Department: Department of Genetics
Education: B.S. Biomedical Engineering, Yale University
|
|
Zhaozhong Jiang, Ph.D.
Research Scientist
|
|
Raman Bahal, Ph.D.
|
|
Alice Gaudin, Ph.D.
Postdoctoral Associate
Department: FASEAS Dept of Biomedical Engineering (SEAS)
Alice is a French engineer. She graduated from the ESPCI ParisTech in 2010 and obtained a Master Degree in Biomedical Engineering in 2011. She received her PhD from the University Paris-Sud. Her research was performed at the Institut Galien Paris-Sud, under the supervision of the Prof Patrick Couvreur, on the development of new nanomedicines for the treatment of stroke and spinal cord injury. Alice joined the Saltzman Lab in February 2015 to work on the delivery of nanoparticles by CED for the treatment of brain tumors.
|
|
Gregory Tietjen, Ph.D.
Postdoctoral Fellow in Biomedical Engineerinig
Department: FASEAS Dept of Biomedical Engineering (SEAS)
|
|
Jennifer Weiser, Ph.D.
Postdoctoral Fellow in Biomedical Engineering
Department: FASEAS Dept of Biomedical Engineering (SEAS)
Education: B.S. Chemical and Biological Engineering, Rensselaer Polytechnic Institute, M.S. Biomedical Engineering, Cornell University, Ph.D. Biomedical Engineering, Cornell University
Research Interests:
Diabetic wound healing and controlled drug delivery. More specifically, developing new methods for the production of electrospun scaffolds based on polycaprolactone and chitosan. These materials will be useful for controlled delivery systems with combinations of agents to enhance the healing of diabetic wounds. Furthermore, a new method is being developed for associating nanoparticles to the fibers in the electrospun scaffolds, to allow for versatility in drug release.
|
|
Jenny Cui, Ph.D.
Department: Department of Biomedical Engineering
Education: B.A., Dartmouth College, M.D., Geisel School of Medicine, M.S., M.Phil., Yale University, Ph.D., Yale University
Research Interests:
I am interested in the synthesis of nanoparticles for sustained delivery of siRNA therapeutics to the vascular endothelium. In addition, I am also interested in the design of vascular perfusion bioreactors to study the interactions between nanoparticles and endothelial cells under flow.
|
|
Amanda King, M.D., Ph.D.
Education: B.S.E., Chemical and Biomolecular Engineering, University of Pennsylvania, Ph.D., Yale University
Research Interests: Drug delivery to intracranial tumors, Radiosensitizing small molecules, Pediatric Neuro-oncology
Research History:
2015-2016: Yale Cancer Center Pre-Doctoral Fellowship
2014-Present: Graduate Student Researcher, Saltzman Lab - Convection-Enhanced Delivery of Radiosensitizer-Encapsulating Nanoparticles for the Treatment of Pediatric Brain Tumors
2012: Special Investigations, Saltzman Lab - siRNA Delivery to Intracranial Tumors Using Polymeric Nanoparticles
2011: Special Investigations, Niklason lab - iPSC Reprogramming Using mRNA Transfection, Yale University
2010: Institute of Regenerative Medicine Fellowship - Tissue Engineering of iPSC-Derived Vessels from Prenatal Fibroblasts, University of Pennsylvania
2009-2011: Undergraduate Researcher in Developmental Biology of Congenital Heart Defects, Gruber Lab, Children’s Hospital of Philadelphia
|
|
Christopher Hoimes, D.O., Ph.D.
Department: Medical Oncology, Investigative Medicine
I am a clinician and clinical investigator in urologic and gastrointestinal cancers in the department of medical oncology. In the laboratory of Professor Saltzman, I am involved in the development of oncologic products through biotechnology as a PhD candidate in Investigative Medicine. My current research projects include drug delivery to prostate and bladder cancers, as well as preclinical development of a small molecule immunomodulating drug.
|
|
Adele Ricciardi, M.D., Ph.D.
Education: B.S. Chemistry and Biology, University of North Carolina at Chapel Hill, Ph.D. Biomedical Engineering, Yale University
|
|
Junwei Zhang, Ph.D.
Department: Dept of Chemical Engineering
Education: B.S. Chemical Engineering, Zhejiang University, China, Ph.D. Chemical Engineering, Yale University
Research Interests: Gene therapy is the treatment of disease by transferring genetic material into specific cells of the patient. It has been heavily investigated for the treatment of many diseases, including cancer. However, since unprotected gene will be easily degraded by endogenous nucleases, the success of gene therapy is largely dependent on the development of gene vectors that can efficiently deliver genes to target cells with minimal toxicity. Cationic polymers are promising candidates because of their facile synthesis, high stability and flexibility in functionalization, but most of them suffer due to low efficiency or high toxicity. Based on the previous research on polymeric gene carriers in the Saltzman Lab, I have synthesized a series of poly (amine-co-esters) containing ortho ester groups and these materials showed significantly higher gene delivery efficiency and greatly lower toxicity than the commercial gene vectors.
Other Interests: Cycling, photography
|
|
Linda Li, M.D.
Education: A.B. Biology, and Asian & Middle Eastern Studies, Dartmouth College, M.D. Yale School of Medicine
Linda graduated from Dartmouth College in 2011 with a dual degree in Biology and Asian & Middle Eastern Studies. Following college, she went on to work as a healthcare strategy consultant advising Fortune 500 pharmaceutical and biotechnology companies on brand strategies, financial forecasting and drug pre-launch planning. Linda is currently a medical student at Yale, she joined the Saltzman lab as a summer student and currently works on assessing the viability of delivering novel polymer nanoparticles to human endothelial tissues. |
|
Christopher Cheng, Ph.D.
Department: Dept of Molecular Biophysics & Biochemistry
|
|
Yang Deng, Ph.D.
Department: Dept of Biomedical Engineering
I received my Ph.D. from Chemistry at the University of Minnesota in 2008. My graduate background was on materials chemistry with a focus on surface modification and characterization on medical devices. I had 3 years’ postdoctoral training on cancer biology in Pharmacology at Yale University. I started my second postdoctoral training at Saltzman lab in the fall of 2011. Currently I am working on designing novel nanoparticles to facilitate the drug delivery for diseases: 1) Surface modification to facilitate target drug delivery; 2) Surface modification to facilitate the nanoparticles across blood brain barrier and mucus; 3) Composite nanoparticles for drug, gene and protein delivery.
Patent
Zhu, X.-Y.; Deng, Y.; Barriet, D.; Wang, Y.; Guo, A.: Air-stable supported lipid bilayer membranes; US Patent 7,858,375 (2010). Patents: <p> </p>
<p><span>[1] Zhu, X.-Y.; Deng, Y.; Barriet, D.; Wang, Y.; Guo, A. “Air-stable supported lipid bilayer membranes,” US Patent 7,858,375 (2010).</span></p>
Research Interests:
Materials chemistry, cancer biology and drug delivery.
Research History: <p> </p>
<p>Research History: I received my Ph.D. from Chemistry at the University of Minnesota in 2008. My graduate background was on materials chemistry with a focus on surface modification and characterization on medical devices. I had 3 years' postdoctoral training on cancer biology in Pharmacology at Yale University. I started my second postdoctoral training at Saltzman lab in the fall of 2011. Currently I am working on designing novel nanoparticles to facilitate the drug delivery for diseases: 1) Surface modification to facilitate target drug delivery; 2) Surface modification to facilitate the nanoparticles across blood brain barrier and mucus; 3) Composite nanoparticles for drug, gene and protein delivery.</p>
|
|
Kseniya Gavrilov, Ph.D.
Department: MCMPHY Educa
Education: B.Sc., Chemistry, University of Chicago, B.Sc., Biological Chemistry, University of Chicago, Ph.D. Cellular and Molecular Physiology, Yale University
Teaching Experience:
Molecular Physiology, Physician’s Associate Program, Lecturer
Physiological Systems, Teaching Fellow
Biotechnology, Teaching Fellow
Molecular Cellular Developmental Biology Lab, Teaching Fellow Research Interests:
siRNA design and delivery. In particular, I am working to develop a potent and specific RNAi-based therapeutic that targets all major forms of fusion oncoprotein BCR-ABL for the treatment of Chronic Myeloid Leukemia.
|
|
Nicole McNeer, M.D., Ph.D.
Department: MPEDI Administration
Education: BA in Physics, Harvard University. Currently in the Yale MD/PhD program.
Research Interests:
Drug delivery, hematopoiesis, hematopoietic stem cells, diseases of the blood and immune system, site-specific gene editing, gene therapy
|
|
Julie Devallière, Ph.D.
Immunobiology and Biomedical Engineering
Research history
The lack of a sufficient blood vessel system represents the main limitation in tissue engineering and regenerative medicine. I work on new methods to promote the formation of vascular network in 3D tissue mimic. In this approach, endothelial cells are transplanted within 3D gel and self-assemble into vessel-like structures in response to growth factors. I test the hypothesis that delivery of specific miRNA or antagomirs, which are regulator of angiogenic process, can further enhance vascular assembly. I use nanoparticles to deliver miRNA to their intracellular targets and test their action in a 3D gel in vitro and in vivo.
Research Interests:
My first research work was carried out in the Sanofi-aventis healthcare group (Toulouse, France) during my professional training as engineer. The research subject was focused on tumor angiogenesis and the validation of therapeutic targets for human cancer. I joined INSERM research unit 643 (Nantes, France) specialized in transplant immunology in 2007 to achieve a Master in Cellular Biology in Dr Béatrice Charreau group. I completed my formation with Ph.D. thesis with financial support of European funding program named Xenome whose aim is to generate the necessary data to allow xenotransplantation to progress towards an initial clinical trial. During three years, I worked on a scientific project designed to explore the role of the signaling adaptor molecule Lnk (SH2B3) in endothelial cell dysfunction associated with transplant rejection. This study demonstrated that modulation of Lnk may be a promising strategy to prevent endothelial cell activation and apoptosis and potentially transplant rejection (Xenotransplantation, 2011). Moreover, I described a new role for Lnk protein as a regulator of the beta1 integrin pathway, influencing adhesion and migration of endothelial cells (FASEB J., under review).
Research History: <p> </p>
<p>The lack of a sufficient blood vessel system represents the main limitation in tissue engineering and regenerative medicine. I work on new methods to promote the formation of vascular network in 3D tissue mimic. In this approach, endothelial cells are transplanted within 3D gel and self-assemble into vessel-like structures in response to growth factors. I test the hypothesis that delivery of specific miRNA or antagomirs, which are regulator of angiogenic process, can further enhance vascular assembly. I use nanoparticles to deliver miRNA to their intracellular targets and test their action in a 3D gel in vitro and in vivo.</p>
|
|
Jillian Andrejecsk, Ph.D.
Department: Dept of Biomedical Engineering
Education: B.S. Biomedical Engineering, Rensselaer Polytechnic Institute, Ph.D. Biomedical Engineering, Yale University
Research History:
Special Investigations, Saltzman Lab: Yale University, Fall 2009
Special Investigations, Kyriakides Lab: Yale University, Spring 2009
Biomedical Engineering Internship Program (BESIP): National Institutes of Health, Summers 2007 & 2008
Undergraduate Research Project (URP): Rensselaer Polytechnic Institute, Fall 2007 – Spring 2008
Research Experience for Undergraduates (REU): Worcester Polytechnic Institute, Summer 2006
Teaching Experience:
Teaching Fellow:
ENAS 551: Biotransport and Kinetics; Yale University (Falls 2009, 2011)
ENAS 535: Biomaterial-Tissue Interactions; Yale University (Spring 2010)
BENG 457: Musculoskeletal Biomechanics; Yale University (Spring 2011) Research Interests:
Vascularization of engineered tissues, pericytes, cell encapsulation, protein delivery Early perfusion is essential for survival and function of engineered tissues. The lack of a functional vascular network is often the limiting factor in tissue engineering and is the reason clinical success in this field has been limited to avascular or thin tissues. My work aims to induce the formation of an extensive and stable vascular network by transplanting endothelial cells within protein gels, a system that can easily be extended the engineering of many tissues. I co-transplant pericytes, a supporting cell in microvessels, to improve maturation and stability of vessels formed. Further, I aim to separate paracrine from contact-dependent signals of pericytes by encapsulating the cells in alginate particles. This allows co-culture with ECs in 3D in vitro culture and in vivo, but prevents PC-EC contact. Other research involves protein delivery to enhance vascular formation.
Research History: <p> </p>
<p>- Special Investigations, Saltzman Lab: Yale University, Fall 2009 - Special Investigations, Kyriakides Lab: Yale University, Spring 2009 - Biomedical Engineering Internship Program (BESIP): National Institutes of Health, Summers 2007 & 2008 - Undergraduate Research Project (URP): Rensselaer Polytechnic Institute, Fall 2007 – Spring 2008 - Research Experience for Undergraduates (REU): Worcester Polytechnic Institute, Summer 2006</p>
|
|
Rachel Jennifer Fields,
Department: Dept of Biomedical Engineering
I am a fifth year PhD student studying novel polymers for gene delivery applications.
|
|
Ben Himes, M.D., Ph.D.
Education: M.D. Yale School of Medicine, Ph.D. Mayo Clinic
I am a medical student conducting research on novel therapies in glioblastoma. I work on developing therapies specifically targeting glioblastoma stem cells, which are likely responsible for tumor initiation and recurrence. I am currently working on identifying genes critical for the function of these cancer stem cells, that are amenable to silencing by siRNA-mediated therapy. I am also interested in the delivery of siRNA and small molecules to glioblastoma stem cells through nanoparticle delivery systems.
|
|
Fan Yang,
Saltzman Lab Manager
Department: FASEAS Biomedical Engineering
Education: B.S., M.S. Biological Science, Georgia State University, M.S. Biomedical Engineering, Yale University
|
|
Hee Won Suh, Ph.D.
Associate Research Scientist
Department: FASEAS Biomedical Engineering
Education: B.S. Chemistry, University of Chicago, Ph.D. Inorganic Chemistry, Yale University
Research Interests:
Hee-Won graduated from University of Chicago in 2010 with a B.S. in Chemistry, where she performed research on Pd catalysts for polymerization of olefins under the direction of Professor Richard F. Jordan. For her Ph.D. in Inorganic Chemistry, she worked with Professor Nilay Hazari at Yale University, where she worked on air-sensitive chemistry toward design of efficient transition-metal-based catalysts, with particular focus on using carbon dioxide as a chemical feedstock. She joined the Saltzman group in August 2015, and she currently works on synthesis and modification of novel polymer-based nano-scale systems for therapeutic applications.
|
|
Anisha Gupta, Ph.D.
Postdoctoral Associate in Therapeutic Radiology
Department: MTRAD Administration
Education: B. Pharm., Punjabi University, India, M.Pharm. (Pharmaceutics), Punjabi University, India, Ph.D., Chemistry, Carnegie Mellon University
Research Interests:
Nucleic acid based therapies focused on the use of Peptide Nucleic Acids (PNA) for gene editing and miRNA targeting.
|
|
Eric Song, M.D., Ph.D.
Department: FASEAS Dept of Biomedical Engineering (SEAS)
Education: B.S. University of Southern California, M.S. Johns Hopkins University, Ph.D. Immunobiology, Yale University, M.D. Yale School of Medicine
Research Interests:
Our current research interests include using a combination of novel nanoparticle systems in conjunction with convection-enhanced delivery to study its efficacy in glioblastoma models. By understanding the particle distribution and cellular effects in vitro and in vivo, we hope to use already approved chemotherapeutics and radiosensitizers to provide possible therapies for the disease.
|
|
Brittany Thompson,
Education: B.S. Biochemistry, Kennesaw State University
Research Interests:
Brittany is a post-baccularate student participating in the Yale Post-baccularate Research Education Program at Yale University. Her current research in the Saltzman laboratory focuses on utilizing Poly(lactic acid)-Poly(ethylene glycol) (PLA-PEG) nanoparticles (NPs) encapsulating rapamycin to enhance delivery and localization of rapamycin to endothelial cells. Her contributions to this project will include three objectives (a) characterization of rapamycin encapsulated PLA-PEG NPs (RPLA-PEG NPs) (b) internalization of RPLGA-PEG NPs by endothelial cells and (c) RPLA-PEG NPs and anti-E selectin antibody conjugation.
|
|
Anthony Bianchi,
Education: B.S., University of Rochester, M.S., Yale University
After completing my master’s degree at Yale, I stayed on as a member of the Saltzman lab to expand upon my research experience. I’m interested in and have worked on several areas in biomedical engineering including problems in gene editing, tissue engineering, and primarily, drug delivery. More specifically, my projects have employed polymeric systems to deliver proteins, nucleic acids, and drugs to various targets. |
|
Muneeb Mohideen, M.D.
Postgraduate Associate in Biomedical Engineering
Department: FASEAS Dept of Biomedical Engineering (SEAS)
Education: B.S., Yale University 2015
|
|
Gina Buzzelli,
Research Assistant and Lab Manager
Education: B.S. Biomedical Engineering, Trinity College
|
|
Zhenghong Peng, Ph.D.
Postdoctoral Associate
Department: FASEAS Dept of Biomedical Engineering (SEAS)
Education: B.S. in Chemical Engineering, Dalian University of Technology, China, Ph.D. in Pharmaceutics, University of Utah
|
|
Amy Kauffman, Ph.D.
Postdoctoral Fellow
Department: FASEAS Dept of Biomedical Engineering (SEAS)
Education: B.S. Biology, Spanish, Bucknell University, Ph.D. Biomedical Engineering, University of Texas Southwestern Medical Center
Research Interests: Amy graduated from Bucknell University in 2011 with a B.S. in Biology and a minor in Spanish, where she performed research in the Functional Morphology Laboratory under the direction of Professor C. Tristan Stayton, PhD. She performed Finite Element Analysis and mechanical testing on the shells of Chrysemys picta to assess the influence of geographic location and predator interactions on the evolution of shell design. For her Ph.D. in Biomedical Engineering, she worked with Professor Joseph Forbess, MD at the University of Texas Southwestern Medical Center at Dallas, where she designed, characterized, and in-vitro assessed novel MRI-visible multi-drug release composite coatings for bioresorbable airway stents. She joined the Saltzman group in May 2016, and is currently working on the development of novel materials to accelerate wound healing in diabetes. The project involves the synthesis of a terpolymer that facilitates siRNA delivery, electrospinning of polymer scaffolds, and testing of these materials for their effectiveness and safety in animal models.
Publications:
- Goodfriend AC, Welch TR, Thomas CE, Nguyen KT, Johnson RF, Forbess JM. Bacterial sensitivity assessment of multifunctional polymeric coatings for airway stents. Journal of Biomedical Materials Research Part B: Applied Biomaterials. July 2016. DOI: 10.1002/jbm.b.33754
- Goodfriend AC, Welch TR, Nguyen KT, Johnson RF, Sebastian V, Reddy SV, Forbess J, Nugent A. Thermally processed polymeric microparticles for year-long delivery of dexamethasone. Materials Science and Engineering C. Sept 2015. DOI: 10.1016/j.msec.2015.09.003
- Goodfriend AC, Welch TR, Wang J, Nguyen KT, Johnson RF, Xu C, Reddy SV, Nugent A, Forbess JM. Design of a radiopaque drug delivery coating for bioresorbable stents. Proceedings of the 14th International Mechanical Engineering Congress & Exposition. American Society of Mechanical Engineers. Aug 2015. DOI: 10.1115/IMECE2015-52146
- Goodfriend AC, Welch TR, Nguyen KT, Wang J, Johnson RF, Reddy SV, Nugent A, Forbess JM. Poly(gadodiamide fumaric acid): A bioresorbable radiopaque and MRI-visible polymer for biomedical application. American Chemical Society Biomaterials Science & Engineering. June 2015. DOI: 10.1021/acsbiomaterials.5b00091
- Goodfriend AC, Barker G, Welch TR, Richard G, Reagel M, Reddy SV, Wang J, Nugent A, Forbess J. Novel Bioresorbable Stent Coating for Drug Release in Congenital Heart Disease Applications. Journal of Biomedical Materials Research Part A. Sept 2014. DOI: 10.1002/jbm.a.35313
|
|
Molly Grun, Ph.D.
Education: B.S. Chemical Engineering, Northwestern University, Ph.D. Chemical Engineering, Yale University
|
|
Alexandra Piotrowski-Daspit, Ph.D.
Postdoctoral Fellow
Education: B.S. Chemical-Biological Engineering and Biology, Massachusetts Institute of Technology, Ph.D. Chemical Engineering, Princeton University
|
|
Tushar Agarwal,
Postgraduate Associate
Department: FASEAS Dept of Biomedical Engineering (SEAS)
Education: B.A., Neuroscience, Vassar College
|
|
Yuhang Jiang, Ph.D.
Postdoctoral Associate
Department: FASEAS Dept of Biomedical Engineering (SEAS)
Education: B.S., Pharmacy, Shanghai Jiao Tong University, Ph.D., Pharmaceutical Sciences, The University of North Carolina at Chapel Hill
|
|
Alex Josowitz, Ph.D.
Department: Department of Biomedical Engineering
Education: B.S. Bioengineering, University of Pittsburgh, Ph.D. Biomedical Engineering, Yale University
|
|
Melanie Reschke, Ph.D.
Graduate School Student
Department: Molecular Biophysics and Biochemistry
Education: B.S. Biology, Macalester College, Ph.D. Molecular Biophysics and Biochemistry, Yale University
|
|
Hanna Mandl,
Postgraduate Associate
Education: B.S. Molecular, Cellular, and Developmental Biology, Yale University
|
|
Kay Nakazawa,
Postgraduate Associate
|
|
Laura Bracaglia, Ph.D.
Postdoctoral Fellow
Education: B.S. Biomedical Engineering, Georgia Institute of Technology, Ph.D. Bioengineering, University of Maryland
|
|
Yongheng Wang,
|
|
Claire Albert, Ph.D.
|
|
Teresa Lee, Ph.D.
Postdoctoral Associate
Education: B.S. Biochemistry specialist and Physics, University of Toronto, PhD. Biochemistry, McGill University
|
|
Douglas Wu,
Postgraduate Associate
Department: FASEAS Biomedical Engineering
|
|
Chun-Yu Lin,
Postgraduate Associate
Department: FASEAS Biomedical Engineering
|
|
Anna Lynn,
MD-PhD Student
|
|
Lexi Suberi,
MD-PhD Student
|
|
Minsoo Khang, Ph.D.
Graduate School Student
Education: B.S. Chemical-Biological Engineering, Massachusetts Institute of Technology, Ph.D. Biomedical Engineering, Yale University
|
|
Julian Grundler,
Graduate School Student
Department: Department of Chemistry
Education: B.S. Chemistry, Rollins College
|
|
Yazhe Wang, Ph.D.
Postdoctoral Associate
Education: B.S. Pharmaceutical Sciences, China Pharmaceutical University, Ph.D. Pharmaceutical Sciences, China Pharmaceutical University
|
|
Kwangsoo Shin, Ph.D.
Postdoctoral Associate
Education: B.S., Seoul National University, Ph.D. Engineering, Seoul National University
|
|
Jinal Pothupitiya, Ph.D.
Postdoctoral Associate
Education: Ph.D. Chemistry, University of Rhode Island
|
|
Zoe Moscato,
Postgraduate Associate
Department: FASEAS Biomedical Engineering
Education: B.S. Biomedical Engineering, University of Connecticut
|
|
David Eaton,
Research Associate
Education: B.S./M.S. Biomedical Engineering, Yale University, M.D. Candidate, Quinnipiac University
|
|
Owen Richfield, Ph.D.
Postdoctoral Fellow
Education: B.S. Mathematics, Tulane University, Ph.D. Bioinnovation, Tulane University
|
|
Jungsoo Chang,
Medical Student
Department: Department of Dermatology
|
|
Emily Deschenes,
Graduate School Student
Education: B.S. Chemical Engineering, University of Michigan, M.S. Pharmaceutical Engineering, University of Michigan
|
|
Chad Binns, M.D.
Clinical Fellow
Department: MEDLAB Laboratory Medicine
Education: B.A. Biology, Hendrix College, M.D. University of Arkansas for Medical Sciences
Research Interests: Chad is a laboratory medicine physician specializing in transfusion medicine with research interests at the intersection of nanoparticle drug delivery systems development and cellular therapies.
Research History: Chad graduated from Hendrix College in 2013 where he studied miRNA therapeutics in a mouse model of prostate cancer. During his time as a medical student at the University of Arkansas for Medical Sciences, he participated in an HHMI-funded medical research fellowship at Janelia Research Campus where he developed fluorescent molecular tools for basic science research.
|
|
Dana V. Akiki, Ph.D.
Postdoctoral Fellow
Education: B.S. Chemical Engineering, Clarkson University, Ph.D. Materials Science and Engineering, Cornell University
|
|
Madalina Ene,
Postgraduate Associate
Department: FASEAS Biomedical Engineering
Education: B.S. Mathematics-Economics, Fordham University, B.S. Chemical Engineering, Columbia University
|
|
Ju Hyun Lee,
Graduate School Student
Department: FASEAS Biomedical Engineering
Education: B.S. Chemistry, Harvard University, M.Phil. Biotechnology, University of Cambridge (UK)
|
|
Bin Gao,
Research Assistant (Temporary)
Department: EASBME Biomedical Engineering
Education: B.S. Business, Pharmacology and Toxicology, University at Buffalo, M.S. Finance, University of New South Wales
|
|
Chang-Hee Whang, Ph.D.
Postdoctoral Associate
Department: EASBME Biomedical Engineering
Education: B.S. Chemistry, University of Texas at Austin, M.S. Pharmaceutical Sciences, University of Mississippi, Ph.D. Biological Sciences, KAIST
|
|
Lauren Harkins,
Graduate School Student
Department: EASBME Biomedical Engineering
|
|
Jake Villanova,
Medical Student
Department: ACACWS College Work Study
Education: B.S. Chemistry, Iona University, Sc.M. Biomedical Engineering, Brown University, Ph.D. Chemistry, Brown University
|
|
Xianzhi Zhang,
Postdoctoral Associate
Department: EASBME Biomedical Engineering
Education: B.S. Chemistry, Nanjing University, Ph.D. Chemistry, University of Massachusetts Amherst
|
|
Laiba Akhtar,
Postgraduate Associate
Department: EASBME Biomedical Engineering
Education: B.S. Chemical Engineering, Yale University
|
